Cite

HARVARD Citation

    Rossi, S. et al. (n.d.). Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. European journal of neurology. 20 (1), pp. 87-94. [Online]. 
  
Back to record